Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bovine chondroitin sulfate is a purified glycosaminoglycan derived from the cartilage of cows. It is a sulfated polysaccharide composed of repeating disaccharide units of N-acetylgalactosamine and glucuronic acid, variably sulfated at the 4 and/or 6 position. It is used primarily as a dietary supplement to support joint health and is sometimes used in pharmaceutical-grade preparations for osteoarthritis management, typically to reduce pain and improve joint function. Mechanistically, chondroitin sulfate is believed to exert chondroprotective, anti-inflammatory, anti-apoptotic, and anti-oxidant effects—helping to inhibit destructive enzymes in cartilage, modulate cytokine activity, reduce cell death in chondrocytes, and scavenge reactive oxygen species[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bovine chondroitin sulfate.